Found: 12
Select item for more details and to access through your institution.
Evaluation of the potential effect of dacomitinib, an EGFR tyrosine kinase inhibitor, on ECG parameters in patients with advanced non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 3, p. 874, doi. 10.1007/s10637-019-00887-0
- By:
- Publication type:
- Article
Predicting Overall Survival and Progression-Free Survival Using Tumor Dynamics in Advanced Breast Cancer Patients.
- Published in:
- AAPS Journal, 2019, v. 21, n. 2, p. 1, doi. 10.1208/s12248-018-0290-x
- By:
- Publication type:
- Article
Analysis of US Food and Drug Administration Oncology Approvals on the Characterization of Hepatic Impairment Effect and Dosing Recommendations.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 4, p. 782, doi. 10.1002/cpt.2505
- By:
- Publication type:
- Article
The effect of mild and moderate hepatic impairment on the pharmacokinetics of valdecoxib, a selective COX-2 inhibitor.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 61, n. 4, p. 247, doi. 10.1007/s00228-005-0909-6
- By:
- Publication type:
- Article
Tumor growth inhibition modeling to support the starting dose for dacomitinib.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 9, p. 1256, doi. 10.1002/psp4.12841
- By:
- Publication type:
- Article
Population Pharmacokinetic and Pharmacodynamic Analysis of Tremelimumab in Patients With Metastatic Melanoma.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 10, p. 1108, doi. 10.1002/jcph.309
- By:
- Publication type:
- Article
Fixed Dosing Versus Body Size–Based Dosing of Therapeutic Peptides and Proteins in Adults.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Fixed Dosing Versus Body Size–Based Dosing of Therapeutic Peptides and Proteins in Adults.
- Published in:
- Journal of Clinical Pharmacology, 2012, v. 52, n. 1, p. 18, doi. 10.1177/0091270010388648
- By:
- Publication type:
- Article
Fixed Dosing Versus Body Size-Based Dosing of Monoclonal Antibodies in Adult Clinical Trials.
- Published in:
- Journal of Clinical Pharmacology, 2009, v. 49, n. 9, p. 1012, doi. 10.1177/0091270009337512
- By:
- Publication type:
- Article
Population pharmacokinetics of inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia and non-Hodgkin lymphoma.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2019, v. 46, n. 3, p. 211, doi. 10.1007/s10928-018-9614-9
- By:
- Publication type:
- Article
An Investigation in the Comparability of the Exposure and Recommended Dose of Selected Pfizer Drugs in East Asian Countries: Is Mutual Usage of Clinical Data Among East Asian Countries Feasible?
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 5, p. 609, doi. 10.1002/jcph.2394
- By:
- Publication type:
- Article
Discordance Between Child‐Pugh and National Cancer Institute Classifications for Hepatic Dysfunction: Implications on Dosing Recommendations for Oncology Compounds.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 1, p. 105, doi. 10.1002/jcph.1702
- By:
- Publication type:
- Article